Jordi
Llop Roig
GlaxoSmithKline (Spain)
Madrid, EspañaPublications en collaboration avec des chercheurs de GlaxoSmithKline (Spain) (4)
2009
-
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET
NeuroImage, Vol. 46, Núm. 2, pp. 447-458
2006
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1 - Pseudoequilibrium interval and quantification methods
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 919-928
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 2 - Ketanserin displacement
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 929-937
2005
-
SPECT of serotonin transporters using123I-ADAM: Optimal imaging time after bolus injection and long-term test-retest in healthy volunteers
Journal of Nuclear Medicine, Vol. 46, Núm. 8, pp. 1301-1309